NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 45 min ago

Notice of Special Interest: Womens Health Research

Tue, 2024-03-26 09:36
Notice NOT-OD-24-079 from the NIH Guide for Grants and Contracts

Notice of Termination of RFA-TR-23-016 Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Mon, 2024-03-25 13:43
Notice NOT-TR-24-022 from the NIH Guide for Grants and Contracts

Notice of Early Expiration of PAR-22-191 "Postdoctoral Research Associate Training (PRAT) Program (Fi2)"

Mon, 2024-03-25 03:37
Notice NOT-GM-24-028 from the NIH Guide for Grants and Contracts

Guidance on Flexibilities for Conducting Semiannual Inspections of Animal Facilities

Fri, 2024-03-22 13:45
Notice NOT-OD-24-075 from the NIH Guide for Grants and Contracts

Notice of Change to RFA-CA-22-045, NCI Outstanding Investigator Award (R35 Clinical Trial Optional)

Fri, 2024-03-22 13:42
Notice NOT-CA-24-038 from the NIH Guide for Grants and Contracts

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

Fri, 2024-03-22 13:39
Funding Opportunity PAR-24-165 from the NIH Guide for Grants and Contracts. The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to provide infrastructure support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. This Notice of Funding Opportunity (NOFO) intends to support innovative, interdisciplinary research in several areas, including basic, NeuroHIV, behavioral and social, integrated biobehavioral, applied, clinical, translational, and implementation science.

Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)

Fri, 2024-03-22 13:37
Funding Opportunity RFA-RM-24-007 from the NIH Guide for Grants and Contracts. The purpose of this Notice Of Funding Opportunity (NOFO) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption in regulatory submissions of genome editing therapeutics.

Notice of Correction to Key Dates Listed in Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowships

Fri, 2024-03-22 13:35
Notice NOT-OD-24-082 from the NIH Guide for Grants and Contracts

Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

Fri, 2024-03-22 12:21
Funding Opportunity PAR-24-164 from the NIH Guide for Grants and Contracts. The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to provide infrastructure support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. This Notice of Funding Opportunity (NOFO) intends to support innovative, interdisciplinary research in several areas, including basic, NeuroHIV, behavioral and social, integrated biobehavioral, applied, clinical, translational, and implementation science.

Guidance on Flexibilities for Conducting Semiannual Program Review

Fri, 2024-03-22 11:10
Notice NOT-OD-24-076 from the NIH Guide for Grants and Contracts

Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)

Thu, 2024-03-21 10:47
Funding Opportunity RFA-AI-24-011 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of clinical research platforms that will enable future clinical trials to determine whether combinations of HIV cure strategies can be effective when optimally tailored to the participants. The ultimate goal is for the results of such proof-of-concept clinical studies to inform the development and prioritization of more broad-based curative strategies that will be effective in all people living with HIV. This NOFO will support multidisciplinary teams to conduct coordinated basic and pre-clinical research to profile participants intact, rebound-competent HIV reservoirs and immunologic backgrounds and use that information to develop and test combinations of HIV curative approaches that are specifically tailored to those participants.

Pages